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Wednesday, February 11, 2015 587aautoimmune diseases, effector memory T cells have a unique ion channel
pattern, therefore they are promising therapeutic targets. A number of ion chan-
nel inhibitors are known as selective inhibitors of T lymphocyte proliferation,
but the data available is contradictory. Our aim was to elucidate this phenom-
enon by investigating how the blockage of ion channels affects the activation
and proliferation of T cells treated previously with different concentrations
of mitogens.
In our experiments human peripheral blood lymphocytes from volunteers were
activated via monoclonal antibodies affecting the TCR-CD3 complex on the
cell surface and the co-stimulator molecule CD28. We applied specific ion
channel blockers acting on the major cationic channels of the T cell, the
Kv1.3, the KCa1.1 and the CRAC channel, either alone or in combination
with rapamycin, the inhibitor of the mammalian target of rapamycin
(mTOR). Five days after the stimulus flow cytometry measurements were per-
formed to determine the extent of cellular viability and proliferation.
Our measurements indicated that ion channel blockers and rapamycin had a
negative dose-dependent effect on the amount of cell division. Simultaneous
application of blockers for each channel along with rapamycin proved to be
the most effective, which indicates that they affect independent regulation
pathways. Upon increasing the rate of stimulation, the anti-proliferative effect
of the blockers diminished. This phenomenon was unknown to date and may
prove to be important in understanding the fine-tuning of T cell activation.
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Voltage gated proton channels (HV1) have been implicated in late stage breast
cancer (Wang et al, 2012. J. Biol. Chem. 287:13877), where HV1 expression
correlated with tumor size and poor prognosis. HV1 knockdown reduced cell
proliferation and migration as well as matrix metalloprotease release. However,
the presence of functional HV1 on cancer cell membranes has not been demon-
strated and the mechanism by which they affect the function of these cells has
not been elucidated.
Here we show the definitive presence of functional HV1 on the membranes of
MDAMB 231 cells, a highly metastatic triple negative cell line. We performed
patch clamp experiments on these cells and were able to detect bona fide
voltage- and pH-gated channels that were perfectly selective for protons. The
membrane density of the channels in these cells was recorded as 3.5 pA/pF
which is roughly 5-fold lower than the 15 pA/pF displayed in neutrophils. In
order to show that HV1 expresses at a level sufficient to impact pH regulation
within these cells, we acid loaded them using the ammonium prepulse tech-
nique and monitored pHi recovery utilizing SEER with SNARF-1. Inhibiting
HV1 with 1 mM Zn2þ slowed recovery from an acid load by 3-fold, demon-
strating that the expression of HV1 on these cells affects pH regulation in
these cells.
We conclude that one mechanism by which HV1 may influence the patho-
physiology of breast cancer is by improving the ability of breast cancer cells
to regulate their internal pH.
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Fungal plant pathogens are a significant threat to crop yield and global food
security and the search for pathogen-specific agricultural fungicide targets is
of high priority. TOK1 is a structurally and functionally unique plasma mem-
brane potassium (Kþ) channel with no known homologues in plants or animals
and is the only passive Kþ ion efflux pathway in fungi. Activation of TOK1
leads to ion dyshomeostasis and cell death. However, little is known about
TOK1 channels in phytopathogenic fungi. Here we describe the distribution,
evolution and molecular conservation of TOK1 homologues across plant fungal
phyla, and the cloning and characterization of TOK1 channels from two phy-
topathogens of significant socio-economic importance. In-silico bioinformatics
identified genes predicted to encode putative TOK1 protein subunits, conform-
ing to the characteristic eight transmembrane domain two pore domain (8TM/
2P) structure, in 204/231 sequenced fungal genomes analysed. Molecular con-servation of TOK1 primary structure was greatest in both pore domains and
flanking pore lining transmembrane domains, TM6 and TM8. MgTOK1 from
Mycosphaerella graminicola (wheat leaf blotch) and FgTOK1 from Fusarium
graminearum (wheat head blight) were cloned by RT-PCR into an expression
vector. cRNA was transcribed in-vitro and injected into Xenopus laevis oocytes
and ionic currents measured by two-electrode voltage clamp after 24-48 hours.
Both cloned TOK1 channels exhibited Kþ selective, non-inactivating,
strongly outwardly-rectifying Kþ currents whose activation threshold was
strictly determined by the transmembrane Kþ gradient, as revealed by isotonic
replacement of extracellular Naþ with Kþ. Channels varied in their voltage-
dependent activation kinetics and distinct from the canonical TOK1 isolate
from Saccharomyces cerevisae, displayed signs of time-dependent deactiva-
tion. This appears to be the first reported molecular identification and charac-
terisation of TOK1 Kþ channels from plant pathogenic fungi.
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Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease attacking
principally freely-moveable joints and affecting approximately 1.3 million in
the US. Recently, joint-resident fibroblast-like synoviocytes in RA (RA-FLS)
have been implicated in disease pathogenesis. We have shown that KCa1.1
is the predominant potassium channel expressed by RA-FLS and by FLS
from the pristane-induced arthritis (PIA) rat model of RA. Blocking KCa1.1
with paxilline or iberiotoxin or reducing its expression with siRNA inhibited
the production of pro-inflammatory cytokines, chemokines, and proteases,
and the invasiveness of both RA- and PIA-FLS. In contrast, the over-
expression of KCa1.1 increased the invasiveness of PIA-FLS and induced
the invasiveness of healthy rat FLS. These data demonstrate a crucial role of
KCa1.1 in regulating the aggressive behavior of FLS during RA.
We induced two models of RA in rats, moderate PIA and severe complete
Freund’s adjuvant collagen-induced arthritis. Treatment with the small mole-
cule KCa1.1 blocker paxilline, starting after onset of clinical signs, significantly
reduced disease severity in both models. However, paxilline can cross the
blood-brain barrier and block all variants of KCa1.1 throughout the body,
thereby inducing side effects that preclude its use as a therapeutic for human
use without significant modification. A strategy to target KCa1.1 on RA-FLS
without side effects in other tissues involves the identification of the b and g
regulatory subunits of KCa1.1 in RA-FLS through qPCR, western blotting,
and patch-clamp electrophysiology. This has the potential for the development
of blockers that selectively target KCa1.1 on RA-FLS and do not enter the cen-
tral nervous system.
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The human chloride channels CLC-Ka and CLC-Kb play a pivotal role in kid-
ney by controlling chloride and water absorption. Both channels require barttin
as an accessory subunit for full activity. Mutations in CLC-Kb and barttin genes
lead to severe renal salt loss while CLC-K gain of function polymorphisms
could predispose to hypertension. Thus, compounds that selectively bind to
CLC-Ka and/or CLC-Kb channels may have a significant therapeutic potential.
Recently, we explored the pharmacological profile of CLC-K/barttin expressed
in mammalian HEK-293 cells and demonstrated that HEK cells represent a
valid biological system to screen CLC-K high affinity blockers (Imbrici et
al., Biochim Biophys Acta, 2014). Here, by using molecular modeling and
patch-clamp technique, we developed a new series of benzofuran derivatives
and evaluated their efficacy on CLC-K channels expressed in HEK 293 cells.
Chemical modifications regarding the hydrophobic group at C-5 and C-3 posi-
tion of the benzofuran nucleus of the lead compounds RT-93 and JBL-44 (IC50
within 10-30 mM range), allowed us to define the structural requirements to
ensure an efficacious CLC-Ka block, finally identifying SRA-36 the most
potent compound so far described, with an IC50 of 2.65 1 mM. Interestingly,
